HCPCS Level IIdrugActive
J8655
Oral netupitant, palonosetro
BETOS: O1E
Effective: 2019-01-01
Referenced in 1 policies
Description
Netupitant 300 mg and palonosetron 0.5 mg, oral
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Akynzeo
Manufacturer
Helsinn Therapeutics (U.S.), Inc.
HCPCS Dosage
300 MG/0.5 MG
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.